Editorial: Endocrine complications of COVID-19: short and long.
作者信息
Asadipooya Kamyar
机构信息
Division of Endocrinology, Diabetes, and Metabolism, Barnstable Brown Diabetes and Obesity Center, University of Kentucky, Lexington, KY, United States.
出版信息
Front Endocrinol (Lausanne). 2025 Aug 4;16:1668201. doi: 10.3389/fendo.2025.1668201. eCollection 2025.
Abstract
摘要
相似文献
1
Editorial: Endocrine complications of COVID-19: short and long.
Front Endocrinol (Lausanne). 2025 Aug 4;16:1668201. doi: 10.3389/fendo.2025.1668201. eCollection 2025.
2
Abnormalities of Endocrine Function Tests in COVID-19-Recovered Individuals.
Indian J Endocrinol Metab. 2025 May-Jun;29(3):325-331. doi: 10.4103/ijem.ijem_32_25. Epub 2025 Jun 28.
3
ACE-2-like enzymatic activity in COVID-19 convalescents with persistent pulmonary symptoms associated with immunoglobulin.
mBio. 2025 Jul 22:e0173525. doi: 10.1128/mbio.01735-25.
4
Oral Administration of Water-Soluble Curcumin Complex Prevents ARDS With the Potential for COVID-19 Treatment.
Phytother Res. 2025 Sep;39(9):3924-3934. doi: 10.1002/ptr.70046. Epub 2025 Jul 16.
5
Exposure to a mixture of per-and polyfluoroalkyl substances modulates pulmonary expression of ACE2 and circulating hormones and cytokines.
Toxicol Appl Pharmacol. 2022 Dec 1;456:116284. doi: 10.1016/j.taap.2022.116284. Epub 2022 Oct 18.
6
Molecular dissection of the role of ACE2 in glucose homeostasis.
Physiol Rev. 2025 Jul 1;105(3):935-973. doi: 10.1152/physrev.00027.2024. Epub 2025 Feb 7.
7
IgM anti-ACE2 autoantibodies in severe COVID-19 activate complement and perturb vascular endothelial function.
JCI Insight. 2022 May 9;7(9):e158362. doi: 10.1172/jci.insight.158362.
8
Expression of SARS-CoV-2 entry receptor ACE2 in human brain and its association with Alzheimer's disease and COVID-19.
Mol Psychiatry. 2025 Apr 6. doi: 10.1038/s41380-025-03006-z.
9
SARS-CoV-2 Cell Entry Factors ACE2 and TMPRSS2 are Expressed in the Pancreas but are Not Enriched in Islet Endocrine Cells.
bioRxiv. 2020 Oct 20:2020.08.31.275719. doi: 10.1101/2020.08.31.275719.
10
Sympathetic remodeling and altered angiotensin-converting enzyme 2 localization occur in patients with cardiac disease but are not exacerbated by severe COVID-19.
Auton Neurosci. 2024 Feb;251:103134. doi: 10.1016/j.autneu.2023.103134. Epub 2023 Dec 1.
本文引用的文献
1
Thyroid disorders and COVID-19: a comprehensive review of literature.
Front Endocrinol (Lausanne). 2025 May 19;16:1535169. doi: 10.3389/fendo.2025.1535169. eCollection 2025.
2
ACE2, a therapeutic target of COVID-19, needs to be treated with caution.
Arch Virol. 2025 May 29;170(7):143. doi: 10.1007/s00705-025-06327-0.
3
Combination of spironolactone and DPP-4 inhibitors for treatment of SARS-CoV-2 infection: a literature review.
Arch Virol. 2024 May 16;169(6):122. doi: 10.1007/s00705-024-06043-1.
Zotero 插件